Developing Pharmacogenomic Reports: Insights from Patients and Clinicians

Increasingly, for a variety of indications, patients have their genomes sequenced and actionable results returned. A subset of returned results is pharmacogenomic (PGx) variants involved in the metabolism or action of medications. Although the impact of these variants on health is well‐documented, little research exists on how to communicate these findings to patients and clinicians. We conducted semistructured interviews with end users to understand how best to communicate PGx results. Overall, patients and clinicians had similar opinions regarding report content, delivery, and application. Unique concerns specific to each stakeholder group were also expressed. Patients wanted an easy‐to‐understand individualized report that clinicians utilized to guide their care. Clinicians wanted reports that were easy‐to‐use, actionable, and integrated into their workflow. Implementation of these reports in a clinical setting will allow for broader user feedback and iterative improvement.

[1]  Todd R. Johnson,et al.  A user-centered framework for redesigning health care interfaces , 2005, J. Biomed. Informatics.

[2]  M. Patton,et al.  Qualitative evaluation and research methods , 1992 .

[3]  E. Armstrong,et al.  Health care professionals' perceptions of the role of pharmacogenomic data. , 2002, Journal of managed care pharmacy : JMCP.

[4]  G. Ginsburg,et al.  Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results , 2011, Genetics in Medicine.

[5]  M. Rudis,et al.  Assessment of the Pharmacogenomics Educational Needs of Pharmacists , 2011, American Journal of Pharmaceutical Education.

[6]  W. Burke,et al.  Pharmacogenetic testing: not as simple as it seems , 2008, Genetics in Medicine.

[7]  Julianne M. O’Daniel,et al.  Public perspectives about pharmacogenetic testing and managing ancillary findings. , 2012, Genetic testing and molecular biomarkers.

[8]  H. McLeod,et al.  Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing. , 2012, Personalized medicine.

[9]  D. Voora,et al.  Delivering pharmacogenetic testing in a primary care setting , 2013, Pharmacogenomics and personalized medicine.

[10]  L. Cavallari,et al.  Stakeholder Views on Pharmacogenomic Testing , 2014, Pharmacotherapy.

[11]  J. Graff Zivin,et al.  US Pharmacists' Effect as Team Members on Patient Care: Systematic Review and Meta-Analyses , 2010, Medical care.

[12]  B. Bernhardt,et al.  Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing. , 2013, Personalized medicine.

[13]  Marc S. Williams,et al.  Enhancing genomic laboratory reports: A qualitative analysis of provider review , 2016, American journal of medical genetics. Part A.

[14]  D. Ledbetter,et al.  The Geisinger MyCode Community Health Initiative: an electronic health record-linked biobank for Precision Medicine research , 2015, Genetics in Medicine.

[15]  Julie A. Johnson,et al.  Pharmacogenetics in clinical practice: how far have we come and where are we going? , 2013, Pharmacogenomics.

[16]  Joann G Elmore,et al.  Inviting Patients to Read Their Doctors' Notes: A Quasi-experimental Study and a Look Ahead , 2011, Annals of Internal Medicine.

[17]  T. Hurlimann,et al.  An evaluation of pharmacists' expectations towards pharmacogenomics. , 2013, Pharmacogenomics.

[18]  S. Haga,et al.  Pharmacogenetic testing: current evidence of clinical utility , 2013, Therapeutic advances in drug safety.

[19]  W. Newman,et al.  Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS. , 2007, Pharmacogenomics.

[20]  Lynn Feldman,et al.  Enhancing genomic laboratory reports from the patients' view: A qualitative analysis , 2015, American journal of medical genetics. Part A.

[21]  Erica A. Bowton,et al.  Stakeholder engagement: a key component of integrating genomic information into electronic health records , 2013, Genetics in Medicine.

[22]  J. Brockmöller,et al.  Patients' and physicians' perspectives on pharmacogenetic testing. , 2006, Pharmacogenomics.

[23]  Bilge Mutlu,et al.  Qualitative Analysis , 1928, Nature.

[24]  Julianne M. O’Daniel,et al.  Survey of U.S. Public Attitudes Towards Pharmacogenetic Testing , 2011, The Pharmacogenomics Journal.

[25]  ZhangJiajie,et al.  A user-centered framework for redesigning health care interfaces , 2005 .

[26]  S. Sansgiry,et al.  The Human Genome Project: Assessing Confidence in Knowledge and Training Requirements for Community Pharmacists , 2003, American Journal of Pharmaceutical Education.

[27]  Joann G Elmore,et al.  Inviting Patients to Read Their Doctors' Notes: Patients and Doctors Look Ahead , 2011, Annals of Internal Medicine.